Last Updated: January 19, 2022    


Research Featured

“Kick and Kill” Strategy Eliminates HIV Cells in 40% of Mice

Contagion Live | January 12, 2022

Latency reversal plus natural killer cells diminish HIV reservoir in vivo

Nature Communications | January 10, 2022


Jennifer Webster-Cyriaque Joins NIDCR as Deputy Director

NIH | November 18, 2021

NIAID Researchers Identify How Two People Controlled HIV After Stopping Treatment

NIH | October 29, 2021

Controlling HIV

Harvard Medical School | September 10, 2021

Moderna set to start human trials of experimental mRNA HIV vaccine - Clinical Trials Arena 

Clinical Trials Arena | August 18, 2021

NIH Makes Substantial New Investment of Over $265M in HIV Cure Research

POZ | August 17, 2021

First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers 

Good News Network | April 17, 2021

Excision BioTherapeutics Has Secured $60M to Proceed with HIV Clinical Trial 

Philadelphia magazine | March 5, 2021

Antibody Infusions Prevent Acquisition of Some HIV Strains, NIH Studies Find | January 26, 2021

News Updates

Understanding Where HIV Hides Offers Clues for a Cure

POZ Magazine | January 17, 2022

Neuropilin-1, a myeloid cell-specific protein, is an inhibitor of HIV-1 infectivity

PNAS | January 11, 2022

Experimental mRNA HIV vaccine shows promise in animals

National Institutes of Health (NIH) | January 11, 2022

Assessment of Oral Health and Prevalence of oral Conditions in Human Immunodeficiency Virus-infected Subjects Visiting Antiretroviral Therapy Centers 

J Pharm Bioallied Sci. (Suppl 2):S1470-S1473. doi: 10.4103/jpbs.jpbs_256_21.

Institute Releases Strategic Plan, New Vision, Mission

NIH | January 2022

HIV patients 'cured' by their own unique biology may harbor secrets to end the global scourge 

Medical Xpress | December 31, 2021

mRNA Vaccine for HIV Looks Promising

Infectious Disease Special Edition | December 9, 2021

Q&A With Capt. Renee Joskow, NIDCR’s New Senior Advisor

NIH | December 2021

What can 35-year-old stool samples tell scientists about HIV/AIDS?

ScienceDaily | December 8, 2021

Novel technique solves structure of the HIV capsid alone and in complex with host factors 

News Medical | November 21, 2021

Patient's immune system 'naturally' cures HIV in the second case of its kind | Live Science 

Live Science | November 20, 2021

Webster-Cyriaque Selected as Deputy Director of NIDCR

UNC Health Care | November 19, 2021

HIV breakthrough offers hope as new vaccine crushes virus in stunning trial results

Daily Express November 12, 2021

Pidotimod and Immunological Activation in Individuals Infected with HIV 

Curr HIV Res. 2021;19(3):260-268. doi: 10.2174/1570162X18666210111102046.

New, highly innovative NIH research awards to address health disparities and advance health equity

NIH | October 13, 2021

Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition 

Viruses. 2021 Oct 6;13(10):2004. doi: 10.3390/v13102004.

Researchers use exosome-based strategy to block HIV in mice

Science Daily | September 21, 2021

NIAID Scientists Find a Key to Hepatitis C Entry into Cells

NIH | September 21, 2021

Researchers advance the use of nanoparticles to deliver HIV/AIDS drugs to the brain

FIU News | September 17, 2021

Temple researchers take another step toward curing HIV

The Philadelphia Inquirer | September 17, 2021

A cure for HIV: Emory receives $23.8 million NIH grant to accelerate research - Emory News Center 

Emory News Center | September 9, 2021

To Stop HIV, Researchers Are Investigating an mRNA Vaccine

Healthline | September 5, 2021

Internet-Based HIV Self-Testing Among Men Who Have Sex With Men Through Pre-exposure Prophylaxis: 3-Month Prospective Cohort Analysis From China

NIH | August 27, 2021

HIV Cure Center at UNC to receive $26M in funding over 5 years

WRAL Tech Wire | August 20, 2021

Can These Three Gene Therapies Get Us Closer to an HIV Cure? 

POZ | August 13, 2021

A Randomized, Open Label, Crossover Phase 1 Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel (the CHARM-03 Study) 

AIDS Res Hum Retroviruses. 2021 Aug 12. doi: 10.1089/AID.2021.0096.

New Nanoparticle Drug Delivery System for HIV/AIDS Treatment 

AZoNano | August 12, 2021

Inflammasome Therapeutics to Develop Dual Sustained-Release HIV Prevention and Birth Control Implant

Business Wire | August 9, 2021

Response to Antiretroviral Therapy

Dove Press | 24 July 2021

Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies

World J Gastrointest Pathophysiol. 2021 Jul 22;12(4):59-83. doi: 10.4291/wjgp.v12.i4.59

  2019 Archives 2020 Archives 2021 Archives